Global Polycystic Kidney Disease Drugs Market Report | 2034

Valued at USD 0.51 billion in 2024, the polycystic kidney disease (PKD) drugs market is projected to grow at a CAGR of 5.90%, reaching USD 0.90 billion by 2034. This growth is fueled by the increasing incidence of autosomal dominant PKD across the 8 major markets and the rising demand for effective treatment options.